StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Illumina, Inc.
NasdaqGS:ILMN
Sector
Location
Market Cap
USD 15.96 B
Share Price
USD 100.80
Avg Daily Volume
2,274,776
Change (1 day)
0.46%
Change (1 year)
-4.25%
Change (YTD)
-24.57%
Illumina, Inc. Total Liabilities for the year ending December 29, 2024: USD 3.93 B
Illumina, Inc. Total Liabilities is USD 3.93 B for the year ending December 29, 2024, a -9.99% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
-
Illumina, Inc. Total Liabilities for the year ending December 31, 2023 was USD 4.37 B, a -22.77% change year over year.
-
Illumina, Inc. Total Liabilities for the year ending January 01, 2023 was USD 5.65 B, a 26.27% change year over year.
-
Illumina, Inc. Total Liabilities for the year ending January 02, 2022 was USD 4.48 B, a 54.86% change year over year.
-
Illumina, Inc. Total Liabilities for the year ending January 03, 2021 was USD 2.89 B, a 6.96% change year over year.
Competitors
Natera, Inc.
USD 161.76
NTRA
+0.19
0.12%
Veracyte, Inc.
USD 27.51
VCYT
-0.07
-0.25%
Schrödinger, Inc.
USD 21.12
SDGR
+0.16
0.76%
Azenta, Inc.
USD 33.23
AZTA
+0.38
1.16%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
RELX Plc
USD 53.17
REL.L
-0.07
-0.14%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Key Data
| Date | Total Liabilities | Shareholders' Equity | Cash and Short-Term Investments | Receivables |
|---|
Competitors
Natera, Inc.
USD 161.76
NTRA
+0.19
0.12%
Veracyte, Inc.
USD 27.51
VCYT
-0.07
-0.25%
Schrödinger, Inc.
USD 21.12
SDGR
+0.16
0.76%
Azenta, Inc.
USD 33.23
AZTA
+0.38
1.16%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
RELX Plc
USD 53.17
REL.L
-0.07
-0.14%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%